lifestyles, and diet. Trends Mol Med. 2023 Oct;29(10):789-801. doi: 10.1016/j.molmed.2023.07.002.
29. Finlay BB, Amato KR, Azad M, et al. The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome. Proc Natl Acad Sci U S A. 2021 Feb 9;118(6):e2010217118.
doi: 10.1073/pnas.2010217118.
30. Saeed NK, Al-Beltagi M, Bediwy AS, El-Sawaf Y, Toema O. Gut microbiota in various childhood disorders: Implication and indications. World J Gastroenterol. 2022 May 14;28(18):1875-1901.
doi: 10.3748/wjg.v28.i18.1875
31. Libertucci J, Young VB. The role of the microbiota in infectious diseases. Nat Microbiol. 2019 Jan;4(1):35-45. doi: 10.1038/s41564-018-0278-4.
32. Dinleyici EC, Martínez-Martínez D, Kara A, et al. Time Series Analysis of the Microbiota of Children Suffering From Acute Infectious Diarrhea and Their Recovery After Treatment. Front
Microbiol. 2018 Jun 12;9:1230. doi: 10.3389/fmicb.2018.01230.
33. Chung The H, Le SH. Dynamic of the human gut microbiome under infectious diarrhea. Curr Opin Microbiol. 2022 Apr;66:79-85. doi: 10.1016/j.mib.2022.01.006.
34. Xia X, Chen J, Cheng Y, et al. Comparative analysis of the lung microbiota in patients with respiratory infections, tuberculosis, and lung cancer: A preliminary study. Front Cell Infect Microbiol.
2022 Nov 1;12:1024867.
35. Suskun C, Kilic O, Yilmaz Ciftdogan D, et al. Intestinal microbiota composition of children with infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and multisystem
inflammatory syndrome (MIS-C). Eur J Pediatr. 2022 Aug;181(8):3175-3191. doi: 10.1007/s00431-022-04494-9.
36. Ma J, Wen S, Dong A, Fan W, Kang Y. Gut Microbiome (Bacteria, Fungi, and Viruses) and HIV Infection: Revealing Novel Treatment Strategies. Mol Nutr Food Res. 2023 Dec;67(23):e2300566.
doi: 10.1002/mnfr.202300566
37. Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2021 Jan;19(1):55-71. doi: 10.1038/s41579-020-0433-9.
38. Geng J, Ni Q, Sun W, Li L, Feng X. The links between gut microbiota and obesity and obesity related diseases. Biomed Pharmacother. 2022 Mar;147:112678. doi: 10.1016/j.biopha.2022.112678.
39. Yang Z, Wang Q, Liu Y, et al. Gut microbiota and hypertension: association, mechanisms and treatment. Clin Exp Hypertens. 2023 Dec 31;45(1):2195135. doi: 10.1080/10641963.2023.2195135.
40. Vallianou N, Christodoulatos GS, Karampela I, et al. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and
Perspectives. Biomolecules. 2021 Dec 31;12(1):56. doi: 10.3390/biom12010056.
41. Plaza-Díaz J, Solis-Urra P, Aragón-Vela J, Rodríguez-Rodríguez F, Olivares-Arancibia J, Álvarez-Mercado AI. Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and
Its Potential as a Biomarker for Prognosis and Diagnosis. Biomedicines. 2021 Feb 3;9(2):145. doi: 10.3390/biomedicines9020145.
42. Iddrisu I, Monteagudo-Mera A, Poveda C, et al. Malnutrition and Gut Microbiota in Children. Nutrients. 2021 Aug 8;13(8):2727. doi: 10.3390/nu13082727.
43. Saus E, Iraola-Guzmán S, Willis JR, Brunet-Vega A, Gabaldón T. Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential. Mol Aspects Med. 2019 Oct;69:93-106. doi:
10.1016/j.mam.2019.05.001.
44. Kandalai S, Li H, Zhang N, Peng H, Zheng Q. The human microbiome and cancer: a diagnostic and therapeutic perspective. Cancer Biol Ther. 2023 Dec 31;24(1):2240084. doi:
10.1080/15384047.2023.2240084.
45. Zhao LY, Mei JX, Yu G, et al. Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications. Signal Transduct Target Ther. 2023 May 13;8(1):201. doi:
10.1038/s41392-023-01406-7.
46. Bashir Y, Khan AU. The interplay between the gut-brain axis and the microbiome: A perspective on psychiatric and neurodegenerative disorders. Front Neurosci. 2022 Oct 28;16:1030694. doi:
10.3389/fnins.2022.1030694.
47. Loh JS, Mak WQ, Tan LKS, et al. Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduct Target Ther. 2024 Feb 16;9(1):37. doi: 10.1038/
s41392-024-01743-1.
48. Chandra S, Sisodia SS, Vassar RJ. The gut microbiome in Alzheimer’s disease: what we know and what remains to be explored. Mol Neurodegener. 2023 Feb 1;18(1):9. doi: 10.1186/s13024-
023-00595-7.
49. Kumar A, Pramanik J, Goyal N, et al. Gut Microbiota in Anxiety and Depression: Unveiling the Relationships and Management Options. Pharmaceuticals (Basel). 2023 Apr 9;16(4):565. doi:
10.3390/ph16040565.
50. Peralta-Marzal LN, Rojas-Velazquez D, Rigters D, et al. A robust microbiome signature for autism spectrum disorder across different studies using machine learning. Sci Rep. 2024 Jan
8;14(1):814. doi: 10.1038/s41598-023-50601-7.
51. Qiu P, Ishimoto T, Fu L, Zhang J, Zhang Z, Liu Y. The Gut Microbiota in Inflammatory Bowel Disease. Front Cell Infect Microbiol. 2022 Feb 22;12:733992. doi: 10.3389/fcimb.2022.733992
52. Wang Y, Wei J, Zhang W, et al. Gut dysbiosis in rheumatic diseases: A systematic review and meta-analysis of 92 observational studies. EBioMedicine. 2022 Jun;80:104055. doi: 10.1016/j.
ebiom.2022.104055.
53. Chen X, Lu Y, Chen T, Li R. The Female Vaginal Microbiome in Health and Bacterial Vaginosis. Front Cell Infect Microbiol. 2021 Apr 7;11:631972. doi: 10.3389/fcimb.2021.631972.
54. Ata B, Yildiz S, Turkgeldi E, et al. The Endobiota Study: Comparison of Vaginal, Cervical and Gut Microbiota Between Women with Stage 3/4 Endometriosis and Healthy Controls. Sci Rep.
2019 Feb 18;9(1):2204. doi: 10.1038/s41598-019-39700-6.
55. Venneri MA, Franceschini E, Sciarra F, Rosato E, D’Ettorre G, Lenzi A. Human genital tracts microbiota: dysbiosis crucial for infertility. J Endocrinol Invest. 2022 Jun;45(6):1151-1160. doi:
10.1007/s40618-022-01752-3.
56. Yazici D, Ogulur I, Pat Y, Babayev H, et al. The epithelial barrier: The gateway to allergic, autoimmune, and metabolic diseases and chronic neuropsychiatric conditions. Semin Immunol. 2023
Nov;70:101846. doi: 10.1016/j.smim.2023.101846.
57. Lee E, Lee SY, Kim HB, Yang SI, et al. Insights from the COCOA birth cohort: The origins of childhood allergic diseases and future perspectives. Allergol Int. 2024 Jan;73(1):3-12. doi:
10.1016/j.alit.2023.09.005.
58. Berni Canani R, Paparo L, Nocerino R, et al. Gut Microbiome as Target for Innovative Strategies Against Food Allergy. Front Immunol. 2019 Feb 15;10:191.
59. Losol P, Wolska M, Wypych TP, Yao L, O’Mahony L, Sokolowska M. A cross talk between microbial metabolites and host immunity: Its relevance for allergic diseases. Clin Transl Allergy. 2024
Feb;14(2):e12339. doi: 10.1002/clt2.12339.
60. Gulliver EL, Young RB, Chonwerawong M, et al. Review article: the future of microbiome-based therapeutics. Aliment Pharmacol Ther. 2022 Jul;56(2):192-208. doi: 10.1111/apt.17049.